BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Aug 27, 2012
 |  BC Extra  |  Company News

FDA refuses to file Lemtrada sBLA

FDA refused to file an sBLA from Genzyme Corp. for Lemtrada alemtuzumab to treat multiple sclerosis. According to Genzyme, the agency asked the company to "modify the presentation of the data sets to enable the agency to better navigate the...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >